Advanced search
Publication Cover
OncoTargets and Therapy Volume 12, 2019 - Issue
Submit an article Journal homepage
63
Views
12
CrossRef citations to date
0
Altmetric
Original Research

The TGF-β/Smad Pathway Inhibitor SB431542 Enhances The Antitumor Effect Of Radiofrequency Ablation On Bladder Cancer Cells

Hong-qing Zhou1 Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University , Qujing City 655000, Yunnan Province, People’s Republic of China
,
Ming-sheng Liu1 Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University , Qujing City 655000, Yunnan Province, People’s Republic of ChinaCorrespondence[email protected]
,
Ti-bin Deng1 Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University , Qujing City 655000, Yunnan Province, People’s Republic of China
,
Ping-bo Xie1 Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University , Qujing City 655000, Yunnan Province, People’s Republic of China
,
Wei Wang1 Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University , Qujing City 655000, Yunnan Province, People’s Republic of China
,
Tao Shao1 Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University , Qujing City 655000, Yunnan Province, People’s Republic of China
,
Yao Wu1 Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University , Qujing City 655000, Yunnan Province, People’s Republic of China
&
Peng Zhang2 Department of Urology, State Key Laboratory of Kidney Diseases, Chinese People’s Liberation Army (PLA) General Hospital/Chinese PLA Medical Academy, Beijing 100853, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 7809-7821 | Published online: 23 Sep 2019

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Poonam Yadav, Priya Kundu, Vipul K. Pandey, Prayag J. Amin, Jisha Nair & Bhavani S. Shankar. (2022) Effects of prolonged treatment of TGF-βR inhibitor SB431542 on radiation-induced signaling in breast cancer cells. International Journal of Radiation Biology 98:11, pages 1630-1644.
Read now
Shuang-wu Lv, Zhen-guo Shi, Xiao-hui Wang, Peng-yi Zheng, Hui-bing Li, Qing-jiang Han & Zhi-jun Li. (2020) Ribosome Binding Protein 1 Correlates with Prognosis and Cell Proliferation in Bladder Cancer. OncoTargets and Therapy 13, pages 6699-6707.
Read now

Articles from other publishers (10)

Jin Cai, Linfang Zhao, Lingdi Li, Jun Lou, Rongjun Tang, Ke Zhang, Qingqing Yu & Weixing Mo. (2023) Ultra‐high‐performance liquid chromatography‐tandem mass spectrometry‐based metabolomics unveils the metabolic alterations in colon cancer mice during CT‐guided radiofrequency ablation. Biomedical Chromatography 37:8.
Crossref
Ashraf Ullah Khan, Adnan Khan, Bushra Shal, Salman Khan, Majid Khan, Rizwan Ahmad & Muhammad Riaz. (2023) The critical role of the phytosterols in modulating tumor microenvironment via multiple signaling: A comprehensive molecular approach. Phytotherapy Research 37:4, pages 1606-1623.
Crossref
Chen-Pang Hou, Ke-Hung Tsui, Syue-Ting Chen, Kang-Shuo Chang, Hsin-Ching Sung, Shu-Yuan Hsu, Yu-Hsiang Lin, Tsui-Hsia Feng & Horng-Heng Juang. (2022) The Upregulation of Caffeic Acid Phenethyl Ester on Growth Differentiation Factor 15 Inhibits Transforming Growth Factor β/Smad Signaling in Bladder Carcinoma Cells. Biomedicines 10:7, pages 1625.
Crossref
Yuan-Yuan Liu, Cheng-Zhi Ding, Jia-Ling Chen, Zheng-Shuai Wang, Bin Yang & Xiao-Ming Wu. (2022) A Novel Small Molecular Inhibitor of DNMT1 Enhances the Antitumor Effect of Radiofrequency Ablation in Lung Squamous Cell Carcinoma Cells. Frontiers in Pharmacology 13.
Crossref
Xiao-zheng Zou, Jun-feng Hao & Xiu-hua Zhou. (2021) Inhibition of SREBP-1 Activation by a Novel Small-Molecule Inhibitor Enhances the Sensitivity of Hepatocellular Carcinoma Tissue to Radiofrequency Ablation. Frontiers in Oncology 11.
Crossref
Alireza Mardomi, Marzieh Ghollasi, Mohsen Korani, Mahsa Panahi, Mohammad Parsa-Kondelaji, Mehdi Sabzichi & Ali Salimi. (2021) Blockade of TGF-βR improves the efficacy of doxorubicin by modulating the tumor cell motility and affecting the immune cells in a melanoma model. Naunyn-Schmiedeberg's Archives of Pharmacology 394:11, pages 2309-2322.
Crossref
Xiao-zheng Zou, Xiu-hua Zhou, Ying-qi Feng, Jun-feng Hao, Bing Liang & Meng-wei Jia. (2021) Novel inhibitor of OCT1 enhances the sensitivity of human esophageal squamous cell carcinoma cells to antitumor agents. European Journal of Pharmacology 907, pages 174222.
Crossref
Yongquan Huang, Liu Liao, Haitao Su, Xinlin Chen, Tao Jiang, Jun Liu & Qiuke Hou. (2021) Psoralen accelerates osteogenic differentiation of human bone marrow mesenchymal stem cells by activating the TGF‑β/Smad3 pathway. Experimental and Therapeutic Medicine 22:3.
Crossref
Kavitha Premkumar & Bhavani S. Shankar. (2020) TGF-βR inhibitor SB431542 restores immune suppression induced by regulatory B–T cell axis and decreases tumour burden in murine fibrosarcoma. Cancer Immunology, Immunotherapy 70:1, pages 153-168.
Crossref
Yan Ma, Ningli Chai, Qiyu Jiang, Zhengyao Chang, Yantao Chai, Xiaojuan Li, Huiwei Sun, Jun Hou & Enqiang Linghu. (2020) DNA methyltransferase mediates the hypermethylation of the microRNA 34a promoter and enhances the resistance of patient-derived pancreatic cancer cells to molecular targeting agents. Pharmacological Research 160, pages 105071.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.